Ceritinib is a tyrosine kinase inhibitor that selectively and potently inhibits anaplastic lymphoma kinase (ALK). In ordinary physiology, ALK features as being a key stage in the event and function of anxious process tissue. On the other hand, chromosomal translocation and fusion give rise to an onc